Literature DB >> 31769058

Acute myeloid leukemia with a novel CPSF6-RARG variant is sensitive to homoharringtonine and cytarabine chemotherapy.

Zhanglin Zhang1,2, Mei Jiang1, Gautam Borthakur3, Shuqing Luan4, Xianbao Huang2,5, Guilin Tang2, Qian Xu5, Dexiang Ji5, Andrew D Boyer2, Fei Li5, Ruibin Huang5, M James You2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2019        PMID： 31769058     DOI： 10.1002/ajh.25689

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  8 in total

Review 1.  Current views on the genetic landscape and management of variant acute promyelocytic leukemia.

Authors:  Xiang Zhang; Jiewen Sun; Wenjuan Yu; Jie Jin
Journal:  Biomark Res       Date:  2021-05-06

Review 2.  RNA-Binding Proteins in Acute Leukemias.

Authors:  Konstantin Schuschel; Matthias Helwig; Stefan Hüttelmaier; Dirk Heckl; Jan-Henning Klusmann; Jessica I Hoell
Journal:  Int J Mol Sci       Date:  2020-05-12       Impact factor: 5.923

3.  Comment on Geoffroy, M.-C.; de Thé, H. Classic and Variants APLs, as Viewed from a Therapy Response. Cancers 2020, 12, 967.

Authors:  Zhan Su; Xin Liu
Journal:  Cancers (Basel)       Date:  2021-11-23       Impact factor: 6.639

Review 4.  Atypical Rearrangements in APL-Like Acute Myeloid Leukemias: Molecular Characterization and Prognosis.

Authors:  Luca Guarnera; Tiziana Ottone; Emiliano Fabiani; Mariadomenica Divona; Arianna Savi; Serena Travaglini; Giulia Falconi; Paola Panetta; Maria Cristina Rapanotti; Maria Teresa Voso
Journal:  Front Oncol       Date:  2022-04-12       Impact factor: 5.738

5.  Solamargine induces autophagy-mediated apoptosis and enhances bortezomib activity in multiple myeloma.

Authors:  Qiaoyan Han; Hua Bai; Yong Xu; Min Zhou; He Zhou; Xiaoqing Dong; Bing Chen
Journal:  Clin Exp Pharmacol Physiol       Date:  2022-03-31       Impact factor: 2.963

6.  Case report: A rare case of acute myeloid leukemia with CPSF6-RARG fusion resembling acute promyelocytic leukemia.

Authors:  Junmei Zhao; Wentao Wang; Li Yan; Xi Chen; Wen Li; Wanying Li; Tingting Chen; Lunhua Chen
Journal:  Front Oncol       Date:  2022-09-15       Impact factor: 5.738

Review 7.  Classic and Variants APLs, as Viewed from a Therapy Response.

Authors:  Marie-Claude Geoffroy; Hugues de Thé
Journal:  Cancers (Basel)       Date:  2020-04-14       Impact factor: 6.639

Review 8.  Targeting the Human 80S Ribosome in Cancer: From Structure to Function and Drug Design for Innovative Adjuvant Therapeutic Strategies.

Authors:  Arnaud Gilles; Léo Frechin; Kundhavai Natchiar; Giulia Biondani; Ottilie von Loeffelholz; Samuel Holvec; Julie-Lisa Malaval; Jean-Yves Winum; Bruno P Klaholz; Jean-François Peyron
Journal:  Cells       Date:  2020-03-05       Impact factor: 6.600
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.